Corepressors of agonist-bound nuclear receptors

Toxicology and Applied Pharmacology

Volumn 223, Issue 3, 2007, Pages 288-298

  Gurevich, Igor ^a   Flores, Anthony M ^a   Aneskievich, Brian J ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Coregulator; Corepressor; Nuclear receptor

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; HISTONE DEACETYLASE; LIGAND DEPENDENT COREPRESSOR PROTEIN; METASTASIS ASSOCIATED FACTOR 1; NR BINDING SET DOMAIN CONTAINING PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA; PROTEIN COPR1; REPRESSOR OF ESTROGEN ACTIVITY; REPRESSOR PROTEIN; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; XENOBIOTIC AGENT;

CONFORMATIONAL TRANSITION; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; TRANSCRIPTION REGULATION; XENOBIOTIC METABOLISM;

ANIMALS; HUMANS; LIGANDS; MODELS, MOLECULAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC;

EID: 34548430174     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.05.019     Document Type: Review

References (58)

1. Ashkar S., Mesentsev A., Zhang W.X., Mastyugin V., Dunn M.W., and Laniado-Schwartzman M. Retinoic acid induces corneal epithelial CYP4B1 gene expression and stimulates the synthesis of inflammatory 12-hydroxyeicosanoids. J. Ocular Pharmacol. Ther. 20 (2004) 65-74
2. Augereau P., Badia E., Balaguer P., Carascossa S., Castet A., Jalaguier S., and Cavailles V. Negative regulation of hormone signaling by RIP140. J. Steroid Biochem. Mol. Biol. 102 (2006) 51-59
3. Barbier O., Villeneuve L., Bocher V., Fontaine C., Torra I.P., Duhem C., Kosykh V., Fruchart J.C., Guillemette C., and Staels B. The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene. J. Biol. Chem. 278 (2003) 13975-13983
4. Colombo A., Bonfanti P., Orsi F., and Camatini M. Differential modulation of cytochrome P-450 1A and P-glycoprotein expression by aryl hydrocarbon receptor agonists and thyroid hormone in Xenopus laevis liver and intestine. Aquat. Toxicol. 63 (2003) 173-186
5. Danielian P.S., White R., Lees J.A., and Parker M.G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11 (1992) 1025-1033
6. Delage-Mourroux R., Martini P.G., Choi I., Kraichely D.M., Hoeksema J., and Katzenellenbogen B.S. Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA. J. Biol. Chem. 275 (2000) 35848-35856
7. Epping M.T., and Bernards R. A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer. Cancer Res. 66 (2006) 10639-10642
8. Epping M.T., Wang L., Edel M.J., Carlee L., Hernandez M., and Bernards R. The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell 122 (2005) 835-847
9. Fernandes I., Bastien Y., Wai T., Nygard K., Lin R., Cormier O., Lee H.S., Eng F., Bertos N.R., Pelletier N., Mader S., Han V.K., Yang X.J., and White J.H. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and-independent mechanisms. Mol. Cell 11 (2003) 139-150
10. Flores A.M., Li L., and Aneskievich B.J. Isolation and functional analysis of a keratinocyte-derived, ligand-regulated nuclear receptor comodulator. J. Invest. Dermatol. 123 (2004) 1092-1101
11. Gibson G.G., Phillips A., Aouabdi S., Plant K., and Plant N. Transcriptional regulation of the human pregnane-X receptor. Drug Metab. Rev. 38 (2006) 31-49
12. Gronemeyer H., Gustafsson J.A., and Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat. Rev., Drug Discov. 3 (2004) 950-964
13. Guo D., Sarkar J., Ahmed M.R., Viswakarma N., Jia Y., Yu S., Sambasiva Rao M., and Reddy J.K. Peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP) but not PPAR-interacting protein (PRIP) is required for nuclear translocation of constitutive androstane receptor in mouse liver. Biochem. Biophys. Res. Commun. 347 (2006) 485-495
14. Harrington W.R., Sengupta S., and Katzenellenbogen B.S. Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells. Endocrinology 147 (2006) 3843-3850
15. Hayes C.L., Spink D.C., Spink B.C., Cao J.Q., Walker N.J., and Sutter T.R. 17 beta-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 9776-9781
16. Howell S.R., Shirley M.A., and Ulm E.H. Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes. Drug Metab. Dispos. 26 (1998) 234-239
17. Hsieh J.C., Sisk J.M., Jurutka P.W., Haussler C.A., Slater S.A., Haussler M.R., and Thompson C.C. Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling. J. Biol. Chem. 278 (2003) 38665-38674
18. Huang Q., Alvares K., Chu R., Bradfield C.A., and Reddy J.K. Association of peroxisome proliferator-activated receptor and Hsp72. J. Biol. Chem. 269 (1994) 8493-8497
19. Huang N., vom Baur E., Garnier J.M., Lerouge T., Vonesch J.L., Lutz Y., Chambon P., and Losson R. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators. EMBO J. 17 (1998) 3398-3412
20. Itoh M., Nakajima M., Higashi E., Yoshida R., Nagata K., Yamazoe Y., and Yokoi T. Induction of human CYP2A6 is mediated by the pregnane X receptor with peroxisome proliferator-activated receptor-gamma coactivator 1alpha. J. Pharmacol. Exp. Ther. 319 (2006) 693-702
21. Jang K.S., Paik S.S., Chung H., Oh Y.H., and Kong G. MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers. Cancer Sci. 97 (2006) 374-379
22. Jia Y., Qi C., Kashireddi P., Surapureddi S., Zhu Y.J., Rao M.S., Le Roith D., Chambon P., Gonzalez F.J., and Reddy J.K. Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver. J. Biol. Chem. 279 (2004) 24427-24434
23. Jia Y., Guo G.L., Surapureddi S., Sarkar J., Qi C., Guo D., Xia J., Kashireddi P., Yu S., Cho Y.W., Rao M.S., Kemper B., Ge K., Gonzalez F.J., and Reddy J.K. Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 12531-12536
24. Kleer C.G., Cao Q., Varambally S., Shen R., Ota I., Tomlins S.A., Ghosh D., Sewalt R.G., Otte A.P., Hayes D.F., Sabel M.S., Livant D., Weiss S.J., Rubin M.A., and Chinnaiyan A.M. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 11606-11611
25. Kurtev V., Margueron R., Kroboth K., Ogris E., Cavailles V., and Seiser C. Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases. J. Biol. Chem. 279 (2004) 24834-24843
26. Li T., and Chiang J.Y. Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression. Drug Metab. Dispos. 34 (2006) 756-764
27. Malloy P.J., Pike J.W., and Feldman D. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr. Rev. 20 (1999) 156-188
28. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., and Evans R.M. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
29. Martini P.G., Delage-Mourroux R., Kraichely D.M., and Katzenellenbogen B.S. Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity. Mol. Cell Biol. 20 (2000) 6224-6232
30. Mazumdar A., Wang R.A., Mishra S.K., Adam L., Bagheri-Yarmand R., Mandal M., Vadlamudi R.K., and Kumar R. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat. Cell Biol. 3 (2001) 30-37
31. McKenna N.J., Lanz R.B., and O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20 (1999) 321-344
32. Min G., Kim H., Bae Y., Petz L., and Kemper J.K. Inhibitory cross-talk between estrogen receptor (ER) and constitutively activated androstane receptor (CAR). CAR inhibits ER-mediated signaling pathway by squelching p160 coactivators. J. Biol. Chem. 277 (2002) 34626-34633
33. Montano M.M., Ekena K., Delage-Mourroux R., Chang W., Martini P., and Katzenellenbogen B.S. An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 6947-6952
34. Moraitis A.N., Giguere V., and Thompson C.C. Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants. Mol. Cell Biol. 22 (2002) 6831-6841
35. Nebert D.W., Dalton T.P., Okey A.B., and Gonzalez F.J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279 (2004) 23847-23850
36. Nishikawa J., Saito K., Goto J., Dakeyama F., Matsuo M., and Nishihara T. New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. Toxicol. Appl. Pharmacol. 154 (1999) 76-83
37. Panagopoulos I., Isaksson M., Billstrom R., Strombeck B., Mitelman F., and Johansson B. Fusion of the NUP98 gene and the homeobox gene HOXC13 in acute myeloid leukemia with t(11;12)(p15;q13). Genes Chromosomes Cancer 36 (2003) 107-112
38. Park S.E., Xu J., Frolova A., Liao L., O'Malley B.W., and Katzenellenbogen B.S. Genetic deletion of the repressor of estrogen receptor activity (REA) enhances the response to estrogen in target tissues in vivo. Mol. Cell Biol. 25 (2005) 1989-1999
39. Perissi V., and Rosenfeld M.G. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev., Mol. Cell Biol. 6 (2005) 542-554
40. Perissi V., Staszewski L.M., McInerney E.M., Kurokawa R., Krones A., Rose D.W., Lambert M.H., Milburn M.V., Glass C.K., and Rosenfeld M.G. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13 (1999) 3198-3208
41. Potter G.B., Zarach J.M., Sisk J.M., and Thompson C.C. The thyroid hormone-regulated corepressor hairless associates with histone deacetylases in neonatal rat brain. Mol. Endocrinol. 16 (2002) 2547-2560
42. Pratt W.B., Galigniana M.D., Morishima Y., and Murphy P.J. Role of molecular chaperones in steroid receptor action. Essays Biochem. 40 (2004) 41-58
43. Privalsky M.L. The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu. Rev. Physiol. 66 (2004) 315-360
44. Rayasam G.V., Wendling O., Angrand P.O., Mark M., Niederreither K., Song L., Lerouge T., Hager G.L., Chambon P., and Losson R. NSD1 is essential for early post-implantation development and has a catalytically active SET domain. EMBO J. 22 (2003) 3153-3163
45. Safe S., Wormke M., and Samudio I. Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells. J. Mammary Gland Biol. Neoplasia 5 (2000) 295-306
46. Schodin D.J., Zhuang Y., Shapiro D.J., and Katzenellenbogen B.S. Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness. J. Biol. Chem. 270 (1995) 31163-31171
47. Strickland S., and Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15 (1978) 393-403
48. Talukder A.H., Gururaj A., Mishra S.K., Vadlamudi R.K., and Kumar R. Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator. Mol. Cell. Biol. 24 (2004) 6581-6591
49. Tatton-Brown K., and Rahman N. Sotos syndrome. Eur. J. Hum. Genet. 15 (2007) 264-271
50. Thompson C.C., and Bottcher M.C. The product of a thyroid hormone-responsive gene interacts with thyroid hormone receptors. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 8527-8532
51. Tsuchiya Y., Nakajima M., Kyo S., Kanaya T., Inoue M., and Yokoi T. Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res. 64 (2004) 3119-3125
52. Wang K., Mendy A.J., Dai G., Luo H.R., He L., and Wan Y.J. Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells. Toxicol. Sci. 92 (2006) 51-60
53. White J.H., Fernandes I., Mader S., and Yang X.J. Corepressor recruitment by agonist-bound nuclear receptors. Vitam. Horm. 68 (2004) 123-143
54. Xu H.E., Stanley T.B., Montana V.G., Lambert M.H., Shearer B.G., Cobb J.E., McKee D.D., Galardi C.M., Plunket K.D., Nolte R.T., Parks D.J., Moore J.T., Kliewer S.A., Willson T.M., and Stimmel J.B. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 415 (2002) 813-817
55. Xu Y., Iwanaga K., Zhou C., Cheesman M.J., Farin F., and Thummel K.E. Selective induction of intestinal CYP3A23 by 1alpha,25-dihydroxyvitamin D3 in rats. Biochem. Pharmacol. 72 (2006) 385-392
56. Yamamoto Y., Moore R., Goldsworthy T.L., Negishi M., and Maronpot R.R. The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res. 64 (2004) 7197-7200
57. Zarach J.M., Beaudoin III G.M., Coulombe P.A., and Thompson C.C. The co-repressor hairless has a role in epithelial cell differentiation in the skin. Development 131 (2004) 4189-4200
58. Zhang J., Huang W., Chua S.S., Wei P., and Moore D.D. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 298 (2002) 422-424